| Ytd | 71.63% | |
| 1y | 70.78% |
| Open | 83.33 | Prev Close | 84.35 | Low | 80.72 | High | 84.04 | Mkt Cap | 6.53B |
| Vol | 311.02K | Avg Vol | 1.92M | EPS | 1.95 | P/E | 43.26 | Forward P/E | 37.59 |
| Beta | 1.13 | Short Ratio | 3.40 | Inst. Own | 108.92% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 69.37 | 200-d Avg | 50.80 | 1yr Est | 89.27 |
HNGE News
Hinge Health has delivered an impressive near-50% rally in just over six weeks. I initially highligh
� 2025 Benzinga.com. Benzinga does not provide investment advice.
Healthcare IT is emerging as AI's next growth story as providers adopt AI to cut costs & improve car
Barclays analyst Saket Kalia maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the
Keybanc analyst Scott Schoenhaus maintains Hinge Health (NYSE:HNGE) with a Overweight and raises
Morgan Stanley analyst Craig Hettenbach maintains Hinge Health (NYSE:HNGE) with a Overweight and
Wells Fargo analyst Stan Berenshteyn maintains Hinge Health (NYSE:HNGE) with a Overweight and rai
Oura Health is prepings its IPO, which will test whether public markets are ready for a new wave of
